NZ222110A - Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder - Google Patents

Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder

Info

Publication number
NZ222110A
NZ222110A NZ222110A NZ22211087A NZ222110A NZ 222110 A NZ222110 A NZ 222110A NZ 222110 A NZ222110 A NZ 222110A NZ 22211087 A NZ22211087 A NZ 22211087A NZ 222110 A NZ222110 A NZ 222110A
Authority
NZ
New Zealand
Prior art keywords
powder
spray
dosage forms
colloidal silica
ethyl cellulose
Prior art date
Application number
NZ222110A
Other languages
English (en)
Inventor
G L Reuter
R G Blank
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NZ222110A publication Critical patent/NZ222110A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ222110A 1986-10-21 1987-10-09 Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder NZ222110A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/921,558 US4771077A (en) 1986-10-21 1986-10-21 Spray dried acetaminophen

Publications (1)

Publication Number Publication Date
NZ222110A true NZ222110A (en) 1989-07-27

Family

ID=25445622

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222110A NZ222110A (en) 1986-10-21 1987-10-09 Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder

Country Status (14)

Country Link
US (1) US4771077A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0265226B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2550363B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR950013752B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE75602T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU590980B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1298199C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3778825D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2032295T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3005045T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE61950B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ222110A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH24376A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA877542B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
US5198228A (en) * 1989-09-14 1993-03-30 Hoechst-Roussel Pharmaceuticals Inc. Direct dry compressible acetaminophen tablet
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition
EP0421582A1 (en) * 1989-10-03 1991-04-10 Warner-Lambert Company Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same
US5251430A (en) 1990-08-10 1993-10-12 Honda Giken Kogyo Kabushiki Kaisha Cutter and housing assembly for lawn mower
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
EP1166801A1 (en) * 1993-06-04 2002-01-02 Warner-Lambert Company Preparations containing silicon dioxide to improve the taste thereof
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2169371A1 (en) * 1993-08-13 1995-02-23 Thomas A. Alexander Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
AUPO637197A0 (en) * 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
AU751497B2 (en) * 1996-04-23 2002-08-15 Mayne Pharma International Pty Ltd Taste masked pharmaceutical compositions
US20040162273A1 (en) * 2003-01-23 2004-08-19 The Procter & Gamble Company Powder pharmaceutical compositions
JP5026675B2 (ja) * 2005-03-08 2012-09-12 洋文 竹内 錠剤、およびその製造方法
US20060292214A1 (en) * 2005-06-03 2006-12-28 Elan Pharma International Limited Nanoparticulate acetaminophen formulations
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420572B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-04-27 1979-07-24
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
ATE17650T1 (de) * 1980-05-20 1986-02-15 Mallinckrodt Inc Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
DE3306012A1 (de) * 1983-02-22 1984-08-23 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung eines freifliessenden paracetamol-granulats
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
KR850700213A (ko) * 1984-02-08 1985-12-26 제이.데스몬드 다비스 아세트 아미노펜 젤라틴 캡슐
US4710519A (en) * 1985-09-30 1987-12-01 Basf Corporation Process for preparing spray dried acetaminophen powder and the powder prepared thereby

Also Published As

Publication number Publication date
EP0265226A3 (en) 1989-07-19
AU590980B2 (en) 1989-11-23
ZA877542B (en) 1989-05-30
AU7951087A (en) 1988-04-28
JP2550363B2 (ja) 1996-11-06
IE61950B1 (en) 1994-11-30
KR950013752B1 (ko) 1995-11-15
GR3005045T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-24
DE3778825D1 (de) 1992-06-11
US4771077A (en) 1988-09-13
JPS63112515A (ja) 1988-05-17
IE872749L (en) 1988-04-21
ES2032295T3 (es) 1993-02-01
PH24376A (en) 1990-06-13
KR880004805A (ko) 1988-06-27
EP0265226B1 (en) 1992-05-06
EP0265226A2 (en) 1988-04-27
CA1298199C (en) 1992-03-31
ATE75602T1 (de) 1992-05-15

Similar Documents

Publication Publication Date Title
NZ222110A (en) Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder
IE872750L (en) Spray-dried acetaminophen (paracetamol)
IE872751L (en) Spray-dried acetaminophen (paracetamol)
NZ222107A (en) Therapeutic powder form of spray-dried acetaminophen and ethylcellulose and pharmaceutical compositions for oral administration thereof
FI890508L (fi) Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi
NO883612D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin.
GR3032101T3 (en) Vehicles for oral administration of a specific pharmaceutically active acid labile substance.
GB8610573D0 (en) Pharmaceutical formulations of acid labile substances
HUT46028A (en) Process for producing pharmaceutical compositions containing oligosaccharides as active components and for producing the active components
HUT34350A (en) Prcess for production of partable pills with deferred decreasing of the reagents
ES546840A0 (es) Un procedimiento para preparar una sal de acido n-acetil- neuraminico
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
PT83016A (en) Process for the preparation of substituted benzamides and benzoates having pharmaceutical activity
MY101916A (en) Etoposide oral dosage form.
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
HUT71555A (en) New pharmaceutical formulations of spiramycine and process to prepare them
AU2203888A (en) The use of certain 6-mercaptopurines for the preparation of a pharmaceutical, and a process for the preparation of the pharmaceutical
HUT45231A (en) Process for producing sulfonamide derivatives of phenyl-sulfonamido-alkyl-amines and pharmaceuticals with antiarhythmic effect comprising the same as active ingredient
IT1139484B (it) Estere del tiadenolo con l'acido procetofenico ad attivita' ipolipidemizzante,procedimento per la sua preparazione e composizioni farmaceutiche a base di detto estere
NO920192D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-alfa-(heteroaryl)benzenetanaminer og anvendelse derav som medikamenter
NO943458D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin